Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Michael Anthony who wrote (230)	1/12/1998 9:53:00 AM
From: Ian@SI	Respond to of 1321

More stats are included in this press release: 50% long term cancer free status after treatment vs 14% for current treatments. About 180,000 new cases annually discovered. With a better treatment, might there be more early discovery? Ian. biz.yahoo.com According to the American Cancer Society, the 5-year survival rate for the 178,000 Americans diagnosed with lung cancer every year is only 14%. The poor survival rate is attributable to the fact that only 15% of lung cancer is detected at an early-stage

To: Michael Anthony who wrote (230)	1/13/1998 8:09:00 PM
From: GuinnessGuy	Read Replies (2) \| Respond to of 1321

Michael, This just came across the wire. Might be big implications for macular degeneration. Would this be a competing drug or one that would actually bring back to life those retinal cells that were damaged? biz.yahoo.com [BIG SNIP] "This meant there could be very quick treatments for macular degeneration, a very common cause of blindness, for skin damage caused by burns and for atherosclerosis, the furring up of the arteries that causes heart disease." [SNIP] Wow, here are more articles from today about the same discovery: biz.yahoo.com biz.yahoo.com biz.yahoo.com Craig